07034/Z/03/Z/Wellcome Trust/United Kingdom[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2006	2
2007	3
2024	0

Page 1

CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.

Orr SJ, Morgan NM, Elliott J, Burrows JF, Scott CJ, McVicar DW, Johnston JA. Orr SJ, et al. Blood. 2007 Feb 1;109(3):1061-8. doi: 10.1182/blood-2006-05-023556. Epub 2006 Sep 28. Blood. 2007. PMID: 17008544 Free article.

The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3.

Hookham MB, Elliott J, Suessmuth Y, Staerk J, Ward AC, Vainchenker W, Percy MJ, McMullin MF, Constantinescu SN, Johnston JA. Hookham MB, et al. Blood. 2007 Jun 1;109(11):4924-9. doi: 10.1182/blood-2006-08-039735. Epub 2007 Feb 22. Blood. 2007. PMID: 17317861 Free article.

SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses.

Orr SJ, Morgan NM, Buick RJ, Boyd CR, Elliott J, Burrows JF, Jefferies CA, Crocker PR, Johnston JA. Orr SJ, et al. J Biol Chem. 2007 Feb 9;282(6):3418-22. doi: 10.1074/jbc.C600216200. Epub 2006 Nov 30. J Biol Chem. 2007. PMID: 17138568 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year